Adalimumab vs Tranylcypromine

## Adalimumab vs Tranylcypromine: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Tranylcypromine**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Tranylcypromine — N/A.

## Chemical Properties

**Type**: Adalimumab — Antibody; Tranylcypromine — Small molecule.